Kenneth Horton
Consigliere Generale presso SENSEONICS HOLDINGS, INC.
Patrimonio netto: 768 738 $ in data 30/04/2024
Profilo
Kenneth L.
Horton is currently the General Counsel at Senseonics Holdings, Inc. He previously served as the Chairman at Lumira Capital (USA) Corp.
From 2012 to 2015, he was the Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. Kenneth also held the position of VP-Acquisitions, Ventures & General Counsel at Revvity, Inc. Prior to that, he was the EVP-Corporate Development & General Counsel at Nordion (Canada), Inc. from 2005 to 2012.
Mr. Horton completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/05/2024 | 1 839 086 ( 0.35% ) | 768 738 $ | 30/04/2024 |
Posizioni attive di Kenneth Horton
Società | Posizione | Inizio |
---|---|---|
SENSEONICS HOLDINGS, INC. | Consigliere Generale | 01/10/2017 |
Precedenti posizioni note di Kenneth Horton
Società | Posizione | Fine |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Consigliere Generale | 20/01/2015 |
NORDION INC | Consigliere Generale | 01/01/2012 |
Lumira Capital (USA) Corp. | Presidente | - |
REVVITY, INC. | Corporate Officer/Principal | - |
Formazione di Kenneth Horton
Dartmouth College | Undergraduate Degree |
Harvard Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
REVVITY, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
SENSEONICS HOLDINGS, INC. | Electronic Technology |
Aziende private | 2 |
---|---|
Nordion (Canada), Inc.
Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
Lumira Capital (USA) Corp. |
- Borsa valori
- Insiders
- Kenneth Horton